Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia. - sprookjes - yvandenbroek - TriplyDB

Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.

Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.

http://www.wikidata.org/entity/Q38811387

about

Opioid system in L-DOPA-induced dyskinesia.Investigational drugs in Phase I and Phase II for Levodopa-induced dyskinesias.Media hype: Patient and scientific perspectives on misleading medical news.Levodopa-induced Dyskinesia: Clinical Features, Pathophysiology, and Medical Management.Surgical Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease.Scopolamine alleviates involuntary lingual movements: tardive dyskinesia or dystonia?4R-Cembranoid Improves Outcomes after 6-Hydroxydopamine Challenge in Both In vitro and In vivo Models of Parkinson's Disease.Factors associated with motor complications in Parkinson's disease.Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.Treatment options for chorea.Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study.Amantadine extended-release capsules for levodopa-induced dyskinesia in patients with Parkinson's disease.[Pharmacological treatment of motor symptoms in Parkinson's diseases].Motor Complications of Dopaminergic Medications in Parkinson's Disease.Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson's disease patients

P2860

Q37589209-81E32BD6-DC09-4F46-A23F-1B265FF1A658 Q39324877-AC6F9486-F6C1-4845-AF8A-A415BEE75C5D Q40458313-4B39592A-4640-4892-9D1D-B164705A5E31 Q41626118-355ECECA-F2A4-4565-9701-4EEF2FD71492 Q41626128-709F02A2-DDA5-410F-A3AB-5F16ADB1975D Q41633984-55BCDAA1-7517-4592-BCF8-5240E6714A7B Q42241279-4701843C-10FE-47BC-BA38-2080F1EF9551 Q42655862-3115717E-5F6D-473D-BA8D-F01C14B0DA2C Q46354756-4C6286A7-241A-41FE-84A9-317EC4401105 Q47977953-16834D09-329B-427D-877C-775A2CEE1BC5 Q48272070-094A55E7-F428-4BCF-B39F-EE1843128FB7 Q52562719-EC8EE56B-1FC7-4E06-90BA-891AE1A93725 Q52703430-97F575B7-5C26-44B2-B404-1936AF19EEF8 Q55279095-77E75699-DD22-4EB8-82EF-D3C133D6611A Q58698708-AB4E462D-5CD5-4290-A64F-FCFFF52319DE

P2860

Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.

http://www.wikidata.org/entity/Q38811387

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.

@en

type

label

Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.

@en

prefLabel

Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.

@en

P1433

Q38811387-B9DB67C8-CD1F-44B4-BB03-7DA27D515B0F

P1476

Q38811387-49070FA7-22CE-4733-8761-66D58E6C9D7E

P2093

Q38811387-69B17837-E92D-4DB0-B7A7-9F6C739BF381

P2860

Q38811387-081B4672-29D2-4E13-A769-49119C7B824F

Q38811387-095D7D77-D6AD-4B16-9D31-10DAFEB4DA26

Q38811387-097B2746-F298-4E42-95BB-D1FF988CB9BE

Q38811387-0BCE388D-E5F0-4654-83FC-3A2F4A77C110

Q38811387-0D58356C-A4E5-4355-A678-DAB5E4FE9E35

Q38811387-0F0EA190-7FA5-48A9-91C7-CC650D240317

Q38811387-0F653DDB-CB43-490B-9F4B-23371D5AC741

Q38811387-11CC0305-A282-433F-B8A6-C7E9A1E2647D

Q38811387-12330F2D-DF72-4FED-BFDF-7EDEC6A69825

Q38811387-12B34355-CD2B-4822-BDA9-ED024480E062

P2888

Q38811387-49330DB9-9396-4676-B311-C7044C2288E8

P304

Q38811387-3CE7C3F1-298C-4D03-8A5F-DCC75F5F2EC5

P31

Q38811387-BAF8F0C4-5A5D-4C03-8B81-50328F876A4F

P356

Q38811387-DEF5573A-469B-4000-85E8-F81A11F0CC8A

P433

Q38811387-89DD22F7-7562-497D-9EC2-8CF20F71EEE7

P478

Q38811387-00309C30-B278-4DD6-8B04-722B8E96EA56

P50

Q38811387-737E648F-8F26-48BD-B907-C0FD77FF8555

P577

Q38811387-8A2D1983-710E-48ED-9535-8534D88CA712

P6179

Q38811387-A5279729-502C-4516-87E6-1BC9B7023B0A

P698

Q38811387-5B688F68-1DB0-4E1B-A626-DF2CDEDA1B28

P921

Q38811387-A819A6C8-703F-4922-8FB8-65AB077EF445

Q38811387-F50CC6A4-95B9-4CD0-8B6E-A7B466C49568

P356

S40265-016-0566-3

P1433

P1476

Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.

@en

P2093

Dhanya Vijayakumar

http://www.w3.org/2001/XMLSchema#string

P2860

Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study.

Respiratory dyskinesia in a patient with Parkinson disease successfully treated with STN DBS

A blinded study of the suppressibility of involuntary movements in Huntington's chorea, tardive dyskinesia, and L-dopa-induced chorea

Idazoxan is ineffective for levodopa-induced dyskinesias in Parkinson's disease

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

Ropinirole monotherapy induced severe reversible dyskinesias in Parkinson's disease.

Advances in functional neurosurgery for Parkinson's disease.

Pathophysiology of levodopa-induced dyskinesia: potential for new therapies.

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study.

Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations.

P2888

s40265-016-0566-3

P304

759-777

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-016-0566-3

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Joseph Jankovic

P577

2016-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1013282423

http://www.w3.org/2001/XMLSchema#string

P698

27091215

http://www.w3.org/2001/XMLSchema#string

P921